Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simran Sindhu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Blood|June 8, 2007
Lipid rafts are required for Kit survival and proliferation signalsThomas Jahn, Erica Leifheit, Stacie Gooch, et al.
Journal for Immunotherapy of Cancer|July 19, 2017
Angiosarcoma treated successfully with anti-PD-1 therapy - a case reportSimran Sindhu, Lana H Gimber, Lee Cranmer, et al.
Blood|June 8, 2007
Direct interaction between Kit and the interleukin-7 receptorThomas Jahn, Simran Sindhu, Stacie Gooch, et al.
Head & Neck|September 15, 2019
Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 diseaseJames E Han, Sun K Yi, Steven Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Blood|June 8, 2007
Lipid rafts are required for Kit survival and proliferation signalsThomas Jahn, Erica Leifheit, Stacie Gooch, et al.
Journal for Immunotherapy of Cancer|July 19, 2017
Angiosarcoma treated successfully with anti-PD-1 therapy - a case reportSimran Sindhu, Lana H Gimber, Lee Cranmer, et al.
Blood|June 8, 2007
Direct interaction between Kit and the interleukin-7 receptorThomas Jahn, Simran Sindhu, Stacie Gooch, et al.
Head & Neck|September 15, 2019
Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 diseaseJames E Han, Sun K Yi, Steven Wang, et al.
Pageof 1